Evaluation of Abdominal Tumors with [F-18] Fluorodeoxyglucose Positron Emission Tomography

Clinical positron imaging : official journal of the Institute for Clinical P.E.T Pub Date : 2000-05-01 DOI:10.1016/S1095-0397(00)00047-9

Satoshi Kunishima MD, Hiroki Taniguchi MD, Akihiro Yamaguchi MD, Toshimori Koh MD, Hisakazu Yamagishi MD

{"title":"Evaluation of Abdominal Tumors with [F-18] Fluorodeoxyglucose Positron Emission Tomography","authors":"Satoshi Kunishima MD, Hiroki Taniguchi MD, Akihiro Yamaguchi MD, Toshimori Koh MD, Hisakazu Yamagishi MD","doi":"10.1016/S1095-0397(00)00047-9","DOIUrl":null,"url":null,"abstract":"<div>Purpose: The purpose of this study was to evaluate the diagnostic usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET).Procedures: We performed FDG-PET in 22 patients with suspected primary or recurrent cancer (23 cases). The FDG-PET findings were compared with the final diagnosis, which was obtained by histological examination of resected, or biopsy specimens and the clinical course.Results: In all patients, the sensitivity, specificity, and the accuracy of FDG-PET were 93.8%, 85.7%, 91.3%, respectively. In the patients with colo-rectal cancer, the sensitivity, specificity, and accuracy were 92.9%, 100%, 94.4%, respectively.Conclusions: FDG-PET was considered to be clinically useful for the detection of primary or recurrent malignant tumors, and for differentiating recurrent tumors from inflammatory scars.</div>","PeriodicalId":80267,"journal":{"name":"Clinical positron imaging : official journal of the Institute for Clinical P.E.T","volume":"3 3","pages":"Pages 91-96"},"PeriodicalIF":0.0000,"publicationDate":"2000-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1095-0397(00)00047-9","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical positron imaging : official journal of the Institute for Clinical P.E.T","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1095039700000479","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 6

Abstract

Purpose: The purpose of this study was to evaluate the diagnostic usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET).

Procedures: We performed FDG-PET in 22 patients with suspected primary or recurrent cancer (23 cases). The FDG-PET findings were compared with the final diagnosis, which was obtained by histological examination of resected, or biopsy specimens and the clinical course.

Results: In all patients, the sensitivity, specificity, and the accuracy of FDG-PET were 93.8%, 85.7%, 91.3%, respectively. In the patients with colo-rectal cancer, the sensitivity, specificity, and accuracy were 92.9%, 100%, 94.4%, respectively.

Conclusions: FDG-PET was considered to be clinically useful for the detection of primary or recurrent malignant tumors, and for differentiating recurrent tumors from inflammatory scars.

查看原文本刊更多论文

[F-18]氟脱氧葡萄糖正电子发射断层扫描对腹部肿瘤的评价

目的:本研究的目的是评估氟-18氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)的诊断价值。方法:我们对22例疑似原发性或复发性癌症患者(23例)进行了FDG-PET检查。将FDG-PET结果与最终诊断进行比较，最终诊断是通过对切除或活检标本进行组织学检查和临床病程得出的。结果:在所有患者中，FDG-PET的敏感性为93.8%，特异性为85.7%，准确性为91.3%。在结直肠癌患者中，其敏感性为92.9%，特异性为100%，准确性为94.4%。结论:FDG-PET在诊断原发性或复发性恶性肿瘤，鉴别复发性肿瘤与炎性瘢痕方面具有临床应用价值。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical positron imaging : official journal of the Institute for Clinical P.E.T

自引率

0.00%

发文量